Related Experiment Video
Updated: Jun 6, 2026
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Potential of casein kinase I in digestive cancer screening
Cristina Modak1, Jianyuan Chai
1Cristina Modak, Jianyuan Chai, Department Research (09-151), VA Long Beach Healthcare System, Long Beach, 90822 and the University of California, Irvine, CA 92697, United States.
Abstract:
Casein kinase I is a group of ubiquitous Serine/Threonine kinases that have been implicated in both normal cellular functions and several pathological conditions including Alzheimer's disease and cancer. Recent findings in colon and pancreatic cancer have brought tremendous attention to these molecules as potential therapeutic targets in treatment of digestive cancers. In this review, we summarize up to date what is known about this family of kinases and their involvement in carcinogenesis and other pathological conditions. Our emphasis is on their implications in digestive cancers and their potential for cancer screening and therapy.
Insights
Casein kinase I (CK1) enzymes are vital in cell functions and diseases like cancer. This review highlights CK1
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Casein kinase I (CK1) comprises a family of serine/threonine kinases.
- CK1 enzymes play crucial roles in fundamental cellular processes.
- Dysregulation of CK1 is linked to various pathological conditions, including neurodegenerative diseases and cancer.
Purpose of the Study:
- To provide an updated review of the casein kinase I family.
- To elucidate the involvement of CK1 in carcinogenesis.
- To emphasize the implications of CK1 in digestive cancers for screening and therapeutic strategies.
Main Methods:
- Literature review of recent findings on casein kinase I.
- Analysis of studies implicating CK1 in cancer development.
- Focus on research related to digestive cancers.
Main Results:
- Casein kinase I is implicated in both normal cellular functions and pathological conditions.
- Recent research highlights CK1's role in colon and pancreatic cancers.
- CK1 family members are potential therapeutic targets for digestive cancers.
Conclusions:
- Casein kinase I plays a significant role in the development of digestive cancers.
- CK1 represents a promising target for novel cancer screening and therapeutic approaches.
- Further research into CK1's function could lead to advancements in oncology.
